(Natural News) With an increasing number of people becoming aware of graphene oxide being identified in covid vaccines, a company called INBRAIN Neuroelectronics demonstrates that graphene-based “neuromodulation” technology using AI-powered neuroelectronics is very real.
A March 30th, 2021 press release published by BusinessWire.com reveals the story:
INBRAIN Neuroelectronics Secures $17 Million in Series A Funding for First AI-Powered Graphene-Brain Interface
Funding enables company to advance first-in-human studies for its flagship product, a less-invasive neuromodulation device for treating neurological conditions using artificial intelligence and graphene electrodes
To be clear, we are not in any way claiming that INBRAIN is involved in covid vaccines. Rather, they state their technology is being used, “for treating epilepsy and Parkinson’s disease.” The point of covering INBRAIN is to reveal that brain-controlling “biocircuits” based on graphene are, in fact, a very real technology.
So-called “fact-checkers” — which are nothing more than disinformation propaganda pushers — routinely claim that graphene isn’t found in vaccines and that graphene biocircuits are a conspiracy theory. INBRAIN Neuroelectronics shows that the fact checkers are lying.
In fact, as INBRAIN says in their own press release, they are, “aiming to establish the safety of graphene as the new standard of care for neurotechnology devices.”
They also describe graphene biocircuits as a kind of platform that can be upgraded:
Less invasive and more intelligent neuroelectronic technologies like ours could provide safer therapies that are upgradable and adaptive in real time…
If that sounds familiar, it’s probably because Moderna, creator of the mRNA covid vaccine, has described its technology as an “operating system” that can be updated and reprogrammed at any time, also.
At the INBRAIN Neuroelectronics website, the company describes itself thusly:
We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders. We use GRAPHENE, the thinnest material known to man to build the new generation of neural interfaces for brain restoration to help patients around the world.
It also quites Prof. A. Fasano, saying, “Graphene is the next big thing in bioengineering materials, which are pillar components to the next gen of electrotherapies in the steadily growing field of neuromodulation.”
The company highlights its technology as being able to “read” a person’s brain,